» Articles » PMID: 34832507

Comprehensive Overview of -Induced and Associated Diseases

Overview
Journal Pathogens
Date 2021 Nov 27
PMID 34832507
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

() is a prevalent protozoan parasite of medical and veterinary significance. It is the etiologic agent of toxoplasmosis, a neglected disease in which incidence and symptoms differ between patients and regions. In immunocompetent patients, toxoplasmosis manifests as acute and chronic forms. Acute toxoplasmosis presents as mild or asymptomatic disease that evolves, under the host immune response, into a persistent chronic disease in healthy individuals. Chronic toxoplasmosis establishes as latent tissue cysts in the brain and skeletal muscles. In immunocompromised patients, chronic toxoplasmosis may reactivate, leading to a potentially life-threatening condition. Recently, the association between toxoplasmosis and various diseases has been shown. These span primary neuropathies, behavioral and psychiatric disorders, and different types of cancer. Currently, a direct pre-clinical or clinical molecular connotation between toxoplasmosis and most of its associated diseases remains poorly understood. In this review, we provide a comprehensive overview on -induced and associated diseases with a focus on available knowledge of the molecular players dictating these associations. We will also abridge the existing therapeutic options of toxoplasmosis and highlight the current gaps to explore the implications of toxoplasmosis on its associated diseases to advance treatment modalities.

Citing Articles

Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections.

Rojas-Pirela M, Andrade-Alviarez D, Rojas V, Marcos M, Salete-Granado D, Chacon-Arnaude M Open Biol. 2025; 15(2):240239.

PMID: 39904372 PMC: 11793985. DOI: 10.1098/rsob.240239.


Immune dynamics throughout life in relation to sex hormones and perspectives gained from gender-affirming hormone therapy.

Yalcinkaya A, Yalcinkaya R, Sardh F, Landegren N Front Immunol. 2025; 15:1501364.

PMID: 39885993 PMC: 11779622. DOI: 10.3389/fimmu.2024.1501364.


The Potential Role of Toxoplasma gondii Infection in Multiple Sclerosis Development: A Seroepidemiological Study in North Khorasan Province, Iran.

Ghahremani A, Ahmadabad H, Javadzadeh S, Shafiei R Acta Parasitol. 2025; 70(1):32.

PMID: 39853416 DOI: 10.1007/s11686-024-00962-4.


Serological Profile of Anti- Antibodies in Liver Transplant Recipients.

Pintos G, Pires F, Zini N, da Silva R, Silva Junior F, da Silva R Trop Med Infect Dis. 2025; 10(1).

PMID: 39852669 PMC: 11769296. DOI: 10.3390/tropicalmed10010018.


Efficacy of amniotic fluid, blood and urine samples for the diagnosis of toxoplasmosis in pregnant women candidates for amniocentesis using serological and molecular techniques.

Abedian R, Esboei B, Kordi S, Roshan H, Hezarjaribi H, Rahmani Z BMC Pregnancy Childbirth. 2024; 24(1):771.

PMID: 39578753 PMC: 11583409. DOI: 10.1186/s12884-024-06979-x.


References
1.
Mendez O, Koshy A . Toxoplasma gondii: Entry, association, and physiological influence on the central nervous system. PLoS Pathog. 2017; 13(7):e1006351. PMC: 5519211. DOI: 10.1371/journal.ppat.1006351. View

2.
Robert-Gangneux F, Meroni V, Dupont D, Botterel F, Garcia J, Brenier-Pinchart M . Toxoplasmosis in Transplant Recipients, Europe, 2010-2014. Emerg Infect Dis. 2018; 24(8):1497-1504. PMC: 6056100. DOI: 10.3201/eid2408.180045. View

3.
Hamdani N, Daban-Huard C, Lajnef M, Richard J, Delavest M, Godin O . Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample. J Affect Disord. 2013; 148(2-3):444-8. DOI: 10.1016/j.jad.2012.11.034. View

4.
Li Y, Zeng Y, Liu M, Lu Y, Liu X, Zhang Y . Development of a risk scoring system for prognostication in HIV-related toxoplasma encephalitis. BMC Infect Dis. 2020; 20(1):923. PMC: 7716502. DOI: 10.1186/s12879-020-05651-x. View

5.
Rodriguez-Diaz J, Martinez-Grueiro M, Martinez-Fernandez A . [Comparative activity of several antibiotics against Toxoplasma gondii in a mouse model]. Enferm Infecc Microbiol Clin. 1993; 11(10):543-6. View